A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, PEHRG214, in HIV-1-infected individuals
Sarah L. Pett, Lisa A. Williams, Richard O. Day, Andrew R. Lloyd, Andrew D. Carr, Kathleen R. Clezy, Sean Emery, Errol Kaplan, Dale A. McPhee, Andrew J. McLachlan, Frank B. Gelder, Sharon R. Lewin, Winston Liauw, Kenneth M. Williams
Research output: Contribution to journal › Article › peer-review
7Scopus
citations
Fingerprint
Dive into the research topics of 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, PEHRG214, in HIV-1-infected individuals'. Together they form a unique fingerprint.